A-Alpha Bio raises $20M Series A led by Madrona to expand Seattle lab and scale protein-discovery platform

University of Washington spinout A-Alpha Bio raised $20 million in Series A funding led by Madrona Venture Group to expand downtown Seattle lab space and grow its machine-learning team for its protein-discovery platform. The company combines computational tools and yeast-based experiments to generate large protein-interaction datasets used to predict therapeutic protein candidates for diseases including COVID-19.

RRandolph Lopez DDavid Younger MMadrona AA-Alpha Bio UUniversity of Washington